• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

The 2021-2022 Flu Vaccine: 10 Frequently Asked Questions

Slideshow

There is something new with the flu and the vaccine against it every year. We summarized answers to 10 questions frequently asked by patients and clinicians alike.

As flu season approaches, the CDC has provided primary care physicians and other health care professionals with guidance and updates on the latest developments in the flu virus itself and flu vaccination.

Find our brief summaries of the CDC’s Frequently Asked Influenza (Flu) Questions: 2021-2022 Season in the slides below.

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Document COVID Sequelae and Primary Care: An Interview with Samoon Ahmad, MD
Related Content
Tsuboya

ACIP Recommends 2nd COVID-19 Shot for Older Adults, Immunocompromised Individuals

Sydney Jennings
October 24th 2024
Article

CDC Director Mandy Cohen endorsed the ACIP's recommendations, which also call for flexible dosing under shared clinical decision making.

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Keith A. Reynolds
October 1st 2024
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

Pfizer-BioNTech COVID-19 Vaccine May Reduce Risk of Long COVID in Older Adults / Image credit: ©Tobias Arhelger/AdobeStock

Pfizer-BioNTech COVID-19 Vaccine May Reduce Risk of Long COVID in Older Adults

Sydney Jennings
October 21st 2024
Article

IDWeek 2024: Older adults vaccinated with BNT162b2 (Comirnaty) had approximately half the odds of developing long COVID vs unvaccinated adults, according to new data.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

Sydney Jennings
April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

Remdesivir Plus Dexamethasone Reduces Mortality Risk among Adults Hospitalized with COVID-19

Remdesivir Plus Dexamethasone Reduces Mortality Risk among Adults Hospitalized with COVID-19

Sydney Jennings
October 10th 2024
Article

Remdesivir plus dexamethasone was associated with reduced 14- and 28-day mortality vs dexamethasone alone, according to a large study of adults hospitalized with COVID-19.

COVID-19 Linked to Long-Term Risk of MACE, Especially Among Adults with non-O Blood Types

COVID-19 Linked to Long-Term Risk of MACE, Especially Among Adults with non-O Blood Types

Sydney Jennings
October 9th 2024
Article

Prior SARS-CoV-2 infection was associated with a 2-fold increased risk for MACE for up to 3 years, even among people with no history of CVD, in a new analysis of UK Biobank data.

© 2024 MJH Life Sciences

All rights reserved.